Pancreatic cancer early detection: Expanding higher-risk group with clinical and metabolomics parameters
Author:
Open Access
- 1 January 2015
- journal article
- review article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 21 (6) , 1707-17
Abstract
Pancreatic ductal adenocarcinoma (PDAC) is the fourth and fifth leading cause of cancer death for each gender in developed countries. With lack of effective treatment and screening scheme available for the general population, the mortality rate is expected to increase over the next several decades in contrast to the other major malignancies such as lung, breast, prostate and colorectal cancers. Endoscopic ultrasound, with its highest level of detection capacity of smaller pancreatic lesions, is the commonly employed and preferred clinical imaging-based PDAC detection method. Various molecular biomarkers have been investigated for characterization of the disease, but none are shown to be useful or validated for clinical utilization for early detection. As seen from studies of a small subset of familial or genetically high-risk PDAC groups, the higher yield and utility of imaging-based screening methods are demonstrated for these groups. Multiple recent studies on the unique cancer metabolism including PDAC, demonstrate the potential for utility of the metabolites as the discriminant markers for this disease. In order to generate an early PDAC detection screening strategy available for a wider population, we propose to expand the population of higher risk PDAC group with combination clinical and metabolomics parameters.Keywords
This publication has 124 references indexed in Scilit:
- Genetic susceptibility to pancreatic cancerMolecular Carcinogenesis, 2011
- p53 regulates biosynthesis through direct inactivation of glucose-6-phosphate dehydrogenaseNature Cell Biology, 2011
- Distant metastasis occurs late during the genetic evolution of pancreatic cancerNature, 2010
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008International Journal of Cancer, 2010
- Pancreatic cancer in chronic pancreatitis; aetiology, incidence, and early detectionBest Practice & Research Clinical Gastroenterology, 2010
- Anthropometric Measures, Body Mass Index, and Pancreatic CancerArchives of internal medicine (1960), 2010
- Body Mass Index and Risk, Age of Onset, and Survival in Patients With Pancreatic CancerJAMA, 2009
- New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancerThe Lancet Oncology, 2009
- Pancreatic Cancer–Associated Diabetes Mellitus: Prevalence and Temporal Association With Diagnosis of CancerGastroenterology, 2008
- Overweight, obesity and cancer: epidemiological evidence and proposed mechanismsNature Reviews Cancer, 2004